CBR-470-1
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-134205A-5MG | 5 mg | 102,00 | Add | |
| HY-134205A-10MMO | 10mM/1mL | 111,00 | Add | |
| HY-134205A-10MG | 10 mg | 165,00 | Add | |
| HY-134205A-25MG | 25 mg | 317,00 | Add | |
| HY-134205A-50MG | 50 mg | 508,00 | Add | |
| HY-134205A-100MG | 100 mg | 837,00 | Add | |
| HY-134205A-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
CBR-470-1 is an inhibitor of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1). CBR-470-1 is also a non-covalent Nrf2 activator. CBR-470-1 protects SH-SY5Y neuronal cells against MPP+-induced cytotoxicity through activation of the Keap1-Nrf2 cascade[1][2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease, Neurological Disease, NF-κB |
| Format | Solubility: DMSO : 200 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 98.03% |
| Molecular Formula | C14H20ClNO4S2 |
| Molecular Weight | 365.89 |
| CAS-Number | 2416095-06-0 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
